Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Arthur T Sands"'
Autor:
Ernestine Lee, Alexandra Borodovsky, Marilena Gallotta, Jose Gomez Romo, Serena Ranucci, Gwenn M Hansen, Arthur T Sands, Ryan Rountree, Cristiana Guiducci
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/388368403fa8435f8ad6c1061e1efde2
Autor:
Qingyun Liu, Sabrina Jeter-Jones, Dawn Bright, Sofia Movérare-Skrtic, Peter Vogel, Jeff Liu, David Potter, Arthur T. Sands, Faika Mseeh, Petra Henning, Ulf H. Lerner, Robert Brommage, David R. Powell, Karin H Nilsson, James E. Tarver, Claes Ohlsson, Andrea Y. Thompson, Gwenn M. Hansen, Jennifer Bardenhagen, Brian Zambrowicz, Melanie K. Shadoan, Jie Cui, Deon Doree
Publikováno v:
Bone Research, Vol 7, Iss 1, Pp 1-12 (2019)
Bone Research
Bone Research
The disability, mortality and costs caused by non-vertebral osteoporotic fractures are enormous. Existing osteoporosis therapies are highly effective at reducing vertebral but not non-vertebral fractures. Cortical bone is a major determinant of non-v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86097837810f29eb2b4926f9c7eafee1
http://link.springer.com/article/10.1038/s41413-018-0038-3
http://link.springer.com/article/10.1038/s41413-018-0038-3
Autor:
Daniel W. Robbins, Nivetha Brathaban, Dane E. Karr, Austin Tenn-McClellan, Arthur T. Sands, Jun Ma, May Tan, Gwenn M. Hansen, Timothy Ingallinera, Jenny McKinnell, Cristiana Guiducci, Ryan Rountree, Aileen Kelly, Zef Konst, Luz Perez, Mark Noviski
Publikováno v:
Blood. 138:2251-2251
Bruton's tyrosine kinase (BTK) plays a key role in cell survival in B cell malignancies, and covalent inhibitors of BTK, such as ibrutinib and acalabrutinib, have proven efficacious in chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f9e8e6d28add21cfafc5080ef439b17
https://doi.org/10.1182/blood-2021-147473
https://doi.org/10.1182/blood-2021-147473
Autor:
Frederick Cohen, Jennifa Gosling, Monisha Mani, Austin Tenn-McClellan, Janine Powers, Whelan Sarah Anne, Arthur T. Sands, Gwenn M. Hansen, Michael T. Lotze
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A107-A107
BackgroundAdoptive cell transfer (ACT) of TIL effects durable responses in patients with melanoma and some epithelial tumors. It is thought that poor in vitro cell expansion and inefficient T-cell migration to the tumor limits the broader application
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e006f16779523570b613911cde3c180
https://doi.org/10.1136/jitc-2021-sitc2021.098
https://doi.org/10.1136/jitc-2021-sitc2021.098
Autor:
Arthur T. Sands, Alexandra Borodovsky, Chris Karim, Austin Tenn-McClellan, Jose Gomez Romo, Gwenn M. Hansen, Jennifa Gosling, Jennifer Stokes, Ryan Rountree, Cristiana Guiducci, Marilena Gallotta, Frederick Cohen
Publikováno v:
Cancer Research. 81:1595-1595
The E3 ubiquitin ligase Casitas B-lineage lymphoma b (CBL-B) is expressed in T cells where it functions as an important negative regulator of immune activation. CBL-B d attenuates T-cell activation initiated by TCR engagement in part by mediating the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b0ac686db4c8d083b06bab8f0fa8c43
https://doi.org/10.1158/1538-7445.am2021-1595
https://doi.org/10.1158/1538-7445.am2021-1595
Autor:
Jennifer Tung, Luz Perez, Timothy Ingallinera, Jordan Ye, Aileen Kelly, May Tan, Ge Peng, Sasha Borodovsky, Zef Konst, Austin Tenn-McClellan, Ryan Rountree, Steve Basham, Jeffrey H. Wu, Jenny McKinnell, Dahlia Weiss, Arthur T. Sands, Cristiana Guiducci, Mark Noviski, Mcintosh Joel, Dane E Karr, Janine Powers, Daniel W. Robbins, Daisuke Kato, Anna Kolobova, Jeffrey T. Mihalic
Publikováno v:
Blood. 136:34-34
Bruton's tyrosine kinase (BTK) plays a key role in cell survival in B cell malignancies, such as chronic lymphocytic leukemia (CLL). Covalent inhibitors of BTK, such as ibrutinib and acalabrutinib, while effective, have been associated with the occur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::492f0dbdb2ad9ad3c62ea1d2da14dc82
https://doi.org/10.1182/blood-2020-141461
https://doi.org/10.1182/blood-2020-141461
Autor:
Paul Strumph, Julio Rosenstock, Bruce W. Bode, Arthur T. Sands, Pablo Lapuerta, Phillip Banks, John B. Buse, Rubina A. Heptulla, Satish K. Garg, Brian Zambrowicz, Marc Rendell, William T. Cefalu
Publikováno v:
Diabetes Care
OBJECTIVE To assess the safety and efficacy of dual sodium–glucose cotransporter (SGLT) 1 and SGLT2 inhibition with sotagliflozin as adjunct therapy to insulin in type 1 diabetes. RESEARCH DESIGN AND METHODS We treated 33 patients with sotagliflozi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c955470f1e98e74071c86429dc8be8e9
http://europepmc.org/articles/PMC4831906
http://europepmc.org/articles/PMC4831906
Publikováno v:
Clinical Investigation. 5:447-456
Excessive serotonin secretion is the hallmark of carcinoid syndrome. It leads to diarrhea, cramping, abdominal pain, wheezing and flushing. It is also associated with serious cardiac valve disease and lower life expectancy. Efforts to control seroton
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4864cfe1ea08088f88dbcdc833f49207
https://doi.org/10.4155/cli.15.10
https://doi.org/10.4155/cli.15.10
Autor:
Arthur T. Sands, Martyn Caplin, Juan W. Valle, Douglas Fleming, Pablo Lapuerta, Brian Zambrowicz, John Ramage, Dieter Hörsch, Thomas Seufferlein, Bertram Wiedenmann, Phillip Banks, Marianne Pavel
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 100:1511-1519
Carcinoid syndrome (CS) is associated with elevated serotonin, diarrhea, flushing, and increased risk of valvular heart disease. Many patients respond to somatostatin analogs initially, but response diminishes in most patients. Additional options are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfc5e9b89339a803eebed964da5f0686
https://doi.org/10.1210/jc.2014-2247
https://doi.org/10.1210/jc.2014-2247
Autor:
Julio Rosenstock, William T. Cefalu, Pablo Lapuerta, Ike Ogbaa, Arthur T. Sands, Brian Zambrowicz, Phillip Banks
Publikováno v:
Diabetes Care
OBJECTIVE To assess the dose-ranging efficacy and safety of LX4211, a dual inhibitor of sodium–glucose cotransporter (SGLT) 1 and SGLT2, in type 2 diabetes. RESEARCH DESIGN AND METHODS Type 2 diabetic patients inadequately controlled on metformin w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b8bbd45f1343063c1dffba1abcf6e9d
https://doi.org/10.2337/dc14-0890
https://doi.org/10.2337/dc14-0890